Max Planck researcher receives €2 million for the development of new biochemical tools for identifying and characterising new disease-realted proteins December 16, 2025[more]
Max Planck chemists develop novel substance with unique inhibition mode targeting the unfolded protein response highjacked by cancer cells September 26, 2025[more]
The first comprehensive transport model of a plasma membrane calcium pump explains its high speed and opens up new avenues for drug development August 21, 2025[more]